IDEXX LABORATORIES INC /DE Income Taxes Paid
IDEXX LABORATORIES INC /DE (IDXX) reported Income Taxes Paid of $107.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE income taxes paid, net for the quarter ending 2026-06-30 was $84.80M, a 30.38% decline year-over-year.
- IDEXX LABORATORIES INC /DE income taxes paid, net for the quarter ending 2026-03-31 was $22.30M, a 42.95% increase year-over-year.
- IDEXX LABORATORIES INC /DE income taxes paid, net for the quarter ending 2025-12-31 was $17.40M, a 76.52% decline year-over-year.
- IDEXX LABORATORIES INC /DE income taxes paid, net for the quarter ending 2025-09-30 was $12.70M, a 91.07% decline year-over-year.
- IDEXX LABORATORIES INC /DE income taxes paid, net for fiscal 2025 was $167.50M, a 45.48% decline from fiscal 2024.
- IDEXX LABORATORIES INC /DE income taxes paid, net for fiscal 2024 was $307.20M, a 59.58% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE income taxes paid, net for fiscal 2023 was $192.50M, a 19.72% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE income taxes paid, net for fiscal 2022 was $239.80M, a 48.30% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $84.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $107.10M 10-Q · filed 2026-08-04 | $124.50M derived: sum of 3 quarters · filed 2026-08-04 | $137.20M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $22.30M 10-Q · filed 2026-05-05 | $39.70M derived: sum of 2 quarters · filed 2026-05-05 | $52.40M derived: sum of 3 quarters · filed 2026-05-05 | $174.20M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $17.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $30.10M derived: sum of 2 quarters · filed 2026-02-20 | $151.90M derived: sum of 3 quarters · filed 2026-08-04 | $167.50M 10-K · filed 2026-02-20 | |
| 2025-09-30 | $12.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $134.50M derived: sum of 2 quarters · filed 2026-08-04 | $150.10M 10-Q · filed 2025-11-03 | $224.20M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $121.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $137.40M 10-Q · filed 2026-08-04 | $211.50M derived: sum of 3 quarters · filed 2026-08-04 | $353.70M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $15.60M 10-Q · filed 2026-05-05 | $89.70M derived: sum of 2 quarters · filed 2026-05-05 | $231.90M derived: sum of 3 quarters · filed 2026-05-05 | $309.60M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $74.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $216.30M derived: sum of 2 quarters · filed 2026-02-20 | $294.00M derived: sum of 3 quarters · filed 2026-02-20 | $307.20M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $142.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $219.90M derived: sum of 2 quarters · filed 2025-11-03 | $233.10M 10-Q · filed 2025-11-03 | $264.70M derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-06-30 | $77.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $90.90M 10-Q · filed 2025-08-04 | $122.50M derived: sum of 3 quarters · filed 2026-02-20 | ||
| 2024-03-31 | $13.20M 10-Q · filed 2025-05-01 | $44.80M derived: sum of 2 quarters · filed 2026-02-20 | |||
| 2023-12-31 | $31.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $192.50M 10-K · filed 2026-02-20 | |||
| 2023-09-30 | $160.90M 10-Q · filed 2024-10-31 | ||||
| 2022-12-31 | $239.80M 10-K · filed 2025-02-21 | ||||
| 2021-12-31 | $161.70M 10-K · filed 2024-02-22 | ||||
| 2020-12-31 | $110.70M 10-K · filed 2023-02-16 | ||||
| 2019-12-31 | $88.00M 10-K · filed 2022-02-16 | ||||
| 2018-12-31 | $69.70M 10-K · filed 2021-02-12 | ||||
| 2017-12-31 | $81.20M 10-K · filed 2020-02-14 | ||||
| 2016-12-31 | $74.70M 10-K · filed 2019-02-15 | ||||
| 2015-12-31 | $54.90M 10-K · filed 2018-02-16 | $54.88M 10-K · filed 2016-02-17 | |||
| 2014-12-31 | $60.20M 10-K · filed 2017-02-17 | $60.24M 10-K · filed 2015-02-17 | |||
| 2013-12-31 | $67.72M 10-K · filed 2016-02-17 | ||||
| 2012-12-31 | $68.92M 10-K · filed 2015-02-17 | ||||
| 2011-12-31 | $44.35M 10-K · filed 2014-02-18 | ||||
| 2010-12-31 | $48.11M 10-K · filed 2013-02-19 | ||||
| 2009-12-31 | $45.73M 10-K · filed 2012-02-17 | ||||
| 2008-12-31 | $49.55M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |